{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:47:14Z","timestamp":1782240434406,"version":"3.54.5"},"reference-count":52,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Climbing Plan of Basic Research Priorities Program of Jiangsu Province","award":["BK20240003"],"award-info":[{"award-number":["BK20240003"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,6,8]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The cyclic GMP-AMP synthase\/stimulator of interferon genes (cGAS-STING) pathway mediates anti-tumor immunity by sensing cytosolic DNA and producing type I interferons, but is frequently suppressed in multiple myeloma (MM), enabling immune evasion. Dexamethasone (DXM), a cornerstone glucocorticoid in MM therapy, is paradoxically combined with immunotherapies despite its immunosuppressive reputation. The mechanisms by which DXM and its glucocorticoid receptor (GR) modulate the MM immune microenvironment remain elusive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the tumor immune microenvironment using single-cell RNA sequencing in 5TMM3VT murine models. STING-knockout mice were employed for genetic validation, and the PP1 inhibitor salubrinal for pharmacological studies. Protein-protein interactions were examined by co-immunoprecipitation, mass spectrometry, and immunofluorescence. NK cell cytotoxicity and macrophage polarization were assessed using co-culture systems with flow cytometry, quantitative real-time PCR, and ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified that GR constitutively recruits the phosphatase PPP1CB to dephosphorylate and inactivate the TBK1-IRF3 complex, thereby suppressing cGAS-STING signaling in MM cells under basal conditions. As the specific ligand of GR, DXM rapidly binds to GR, leading to the disruption of the GR-PPP1CB-TBK1-IRF3 complex, which in turn reactivates STING signaling and induces interferon-stimulated gene expression. Single-cell analysis revealed that DXM remodeled the immune microenvironment, enhancing NK cell cytotoxicity, and promoting M1-like macrophage polarization. These immunostimulatory effects were abrogated in STING-deficient models. Pharmacological inhibition of PP1 with salubrinal recapitulated DXM\u2019s effects, synergized with bortezomib to prolong survival\n                      <jats:italic>in vivo<\/jats:italic>\n                      , and enhanced daratumumab-mediated antibody-dependent cellular cytotoxicity (ADCC).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study uncovers a glucocorticoid-sensitive inhibitory axis wherein GR-PPP1CB constitutively suppresses STING-TBK1-IRF3 signaling in MM. DXM relieves this suppression, reactivating innate anti-tumor immunity. PP1 inhibition represents a promising therapeutic strategy to enhance anti-myeloma immunity and overcome immune evasion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015256","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:55:23Z","timestamp":1782237323000},"page":"e015256","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Dexamethasone activates anti-tumor immunity in multiple myeloma by dismantling the GR-PPP1CB complex to restore STING\/IRF3 signaling"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct04144140","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03937141","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Chen","family":"Wang","sequence":"first","affiliation":[{"name":"Nanjing Hospital of Chinese Medicine affiliated, Nanjing University of Chinese Medicine, Nanjing, China"},{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiale","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanliang","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lv","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxin","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziang","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Ni","sequence":"additional","affiliation":[{"name":"Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gu","sequence":"additional","affiliation":[{"name":"Nanjing Hospital of Chinese Medicine affiliated, Nanjing University of Chinese Medicine, Nanjing, China"},{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-5102","authenticated-orcid":false,"given":"Ye","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"2026062310551498000_14.6.e015256.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.12.024"},{"key":"2026062310551498000_14.6.e015256.2","doi-asserted-by":"crossref","first-page":"101143","DOI":"10.1016\/j.beha.2020.101143","article-title":"Monoclonal antibodies in multiple myeloma: Current and emerging targets and mechanisms of action","volume":"33","author":"Wudhikarn","year":"2020","journal-title":"Best Pract Res Clin Haematol"},{"key":"2026062310551498000_14.6.e015256.3","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026062310551498000_14.6.e015256.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401456"},{"key":"2026062310551498000_14.6.e015256.5","doi-asserted-by":"crossref","first-page":"188430","DOI":"10.1016\/j.bbcan.2020.188430","article-title":"Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies","volume":"1874","author":"Clarisse","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026062310551498000_14.6.e015256.6","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.2.943"},{"key":"2026062310551498000_14.6.e015256.7","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41423-021-00686-9","article-title":"Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model","volume":"18","author":"Thangaraj","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"2026062310551498000_14.6.e015256.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-775122"},{"key":"2026062310551498000_14.6.e015256.9","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2012STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J Hematol Oncol"},{"key":"2026062310551498000_14.6.e015256.10","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3558"},{"key":"2026062310551498000_14.6.e015256.11","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3510"},{"key":"2026062310551498000_14.6.e015256.12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00711","article-title":"Targeting Cytosolic Nucleic Acid-Sensing Pathways for Cancer Immunotherapies","volume":"9","author":"Iurescia","year":"2018","journal-title":"Front Immunol"},{"key":"2026062310551498000_14.6.e015256.13","doi-asserted-by":"publisher","DOI":"10.1038\/nature24050"},{"key":"2026062310551498000_14.6.e015256.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.09.016"},{"key":"2026062310551498000_14.6.e015256.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-021-01380-0","article-title":"CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma","volume":"20","author":"Gu","year":"2021","journal-title":"Mol Cancer"},{"key":"2026062310551498000_14.6.e015256.16","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407681","article-title":"PNPO\u2010Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt\/\u03b2\u2010Catenin Pathway","volume":"12","author":"Deng","year":"2025","journal-title":"Advanced Science"},{"key":"2026062310551498000_14.6.e015256.17","doi-asserted-by":"crossref","first-page":"101344","DOI":"10.1016\/j.drup.2025.101344","article-title":"DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma","volume":"85","author":"Deng","year":"2026","journal-title":"Drug Resist Updat"},{"key":"2026062310551498000_14.6.e015256.18","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/j.apsb.2025.02.011","article-title":"SAE1 promotes tumor cell malignancy via SUMOylation and liquid\u2013liquid phase separation facilitated nuclear export of p27","volume":"15","author":"Wang","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"2026062310551498000_14.6.e015256.19","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2026062310551498000_14.6.e015256.20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013697","article-title":"Targeting macrophage-derived SPP1 enhances CD8 T cell infiltration via ROS-DNA fragment\/cGAS-STING\/STAT1-mediated CXCL9\/10 in tumor microenvironment","volume":"14","author":"Wang","year":"2026","journal-title":"J Immunother Cancer"},{"key":"2026062310551498000_14.6.e015256.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.09.007"},{"key":"2026062310551498000_14.6.e015256.22","doi-asserted-by":"crossref","first-page":"104656","DOI":"10.1016\/j.dci.2023.104656","article-title":"Yellow catfish RIO kinases (RIOKs) negatively regulate fish interferon-mediated antiviral response","volume":"142","author":"Zhao","year":"2023","journal-title":"Dev Comp Immunol"},{"key":"2026062310551498000_14.6.e015256.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-025-02380-0","article-title":"Demystifying the cGAS-STING pathway: precision regulation in the tumor immune microenvironment","volume":"24","author":"Wang","year":"2025","journal-title":"Mol Cancer"},{"key":"2026062310551498000_14.6.e015256.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.017"},{"key":"2026062310551498000_14.6.e015256.25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41577-024-01112-7","article-title":"Regulation of cGAS-STING signalling and its diversity of cellular outcomes","volume":"25","author":"Zhang","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"2026062310551498000_14.6.e015256.26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98765"},{"key":"2026062310551498000_14.6.e015256.27","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-021-00746-6","article-title":"BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"2026062310551498000_14.6.e015256.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.12.001"},{"key":"2026062310551498000_14.6.e015256.29","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0387"},{"key":"2026062310551498000_14.6.e015256.30","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15618","article-title":"DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity","volume":"8","author":"Vanpouille-Box","year":"2017","journal-title":"Nat Commun"},{"key":"2026062310551498000_14.6.e015256.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.01.008"},{"key":"2026062310551498000_14.6.e015256.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.12.029"},{"key":"2026062310551498000_14.6.e015256.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.01.003"},{"key":"2026062310551498000_14.6.e015256.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.07.001"},{"key":"2026062310551498000_14.6.e015256.35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0012"},{"key":"2026062310551498000_14.6.e015256.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00849-1"},{"key":"2026062310551498000_14.6.e015256.37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609890","article-title":"Protein Phosphatase PP1 Negatively Regulates IRF3 in Response to GCRV Infection in Grass Carp (Ctenopharyngodon idella)","volume":"11","author":"Hu","year":"2020","journal-title":"Front Immunol"},{"key":"2026062310551498000_14.6.e015256.38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600924"},{"key":"2026062310551498000_14.6.e015256.39","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0047"},{"key":"2026062310551498000_14.6.e015256.40","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-025-04152-8","article-title":"PARP1 trapping activates cGAS-STING pathway to induce immunogenic cell death in multiple myeloma","volume":"26","author":"Juli","year":"2026","journal-title":"Cancer Cell Int"},{"key":"2026062310551498000_14.6.e015256.41","doi-asserted-by":"crossref","first-page":"176716","DOI":"10.1016\/j.ejphar.2024.176716","article-title":"Proteasome inhibitors FHND6091 enhance the ability of NK cells to kill tumor cells through multiple mechanisms","volume":"977","author":"Liu","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"2026062310551498000_14.6.e015256.42","doi-asserted-by":"crossref","first-page":"11593","DOI":"10.1038\/s41598-024-62298-3","article-title":"Treg-derived TGF-\u03b21 dampens cGAS-STING signaling to downregulate the expression of class I MHC complex in multiple myeloma","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci Rep"},{"key":"2026062310551498000_14.6.e015256.43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41416-024-02742-3","article-title":"Disruption of DNA-PKcs-mediated cGAS retention on damaged chromatin potentiates DNA damage-inducing agent-induced anti-multiple myeloma activity","volume":"131","author":"Zhang","year":"2024","journal-title":"Br J Cancer"},{"key":"2026062310551498000_14.6.e015256.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2006.11.006"},{"key":"2026062310551498000_14.6.e015256.45","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2022.2136950"},{"key":"2026062310551498000_14.6.e015256.46","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.bbi.2017.09.004","article-title":"Chromatin organization as an indicator of glucocorticoid induced natural killer cell dysfunction","volume":"67","author":"Misale","year":"2018","journal-title":"Brain Behav Immun"},{"key":"2026062310551498000_14.6.e015256.47","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2291"},{"key":"2026062310551498000_14.6.e015256.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.05.001"},{"key":"2026062310551498000_14.6.e015256.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2003.08.006"},{"key":"2026062310551498000_14.6.e015256.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2008.12.013"},{"key":"2026062310551498000_14.6.e015256.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2003.11.008"},{"key":"2026062310551498000_14.6.e015256.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2007.04.014"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:55:26Z","timestamp":1782237326000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,23]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/jitc-2026-015256"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015256","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}